Official FDA announcement: 4) What the studies actually did (no hype, no hand-waving) The FDA says the approval was based on two randomized, double-blind, placebo-controlled studies in adults with obesity and moderate-to-severe OSA, treated for 52 weeks
Peripheral neuropathy affects millions of people and is a growing concern, particularly amongst individuals living with diabetes and those who have long term nutritional absorption issues
Pisano C, Pratesi G, Laccabue D, et al
What factors should we weigh in our consideration of the utility of GLP-1 agonists
Clinics offer both in-person and sometimes telehealth options
As the battery voltage closes in on 95% charge voltage, the charger will automatically start reducing the charge current and then apply a constant voltage for the remaining phase of the charge cycle